1. Home
  2. LUNR vs TARS Comparison

LUNR vs TARS Comparison

Compare LUNR & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$13.31

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$60.12

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
TARS
Founded
2013
2016
Country
United States
United States
Employees
525
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LUNR
TARS
Price
$13.31
$60.12
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$22.35
$89.00
AVG Volume (30 Days)
8.4M
1.3M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$343.00
$56.43
Revenue Next Year
$16.81
$30.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$7.78
$38.51
52 Week High
$46.75
$85.25

Technical Indicators

Market Signals
Indicator
LUNR
TARS
Relative Strength Index (RSI) 28.33 49.15
Support Level $12.70 $56.05
Resistance Level $22.25 $67.14
Average True Range (ATR) 1.00 3.38
MACD 0.23 -0.11
Stochastic Oscillator 7.69 37.27

Price Performance

Historical Comparison
LUNR
TARS

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: